ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018
May 31, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA -May...
ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update
May 16, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
-Key First Quarter 2018 Clinical...
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018
May 08, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA - May...
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)
April 23, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA...
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City
April 16, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA -...
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018
March 26, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA -...
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
March 09, 2018 08:46 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pipeline Achievements in 2017 Included...
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
March 09, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pipeline Achievements in 2017 Included...
ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018
March 02, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland and Boston, MA -...
ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting
March 01, 2018 07:00 ET
|
ObsEva SA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Oral administration of OBE022 shows...